Advertisement
Screener

Opus Genetics, Inc. (IRD) Shares Authorized

2.8 / 5 stars · 68/120 Roast Me

Opus Genetics, Inc. Shares Authorized

Opus Genetics, Inc. (IRD) had Shares Authorized of 250.00 million shares as of 2026-06-30, per its 10-Q filed 2026-08-06.

Financial Statements › Balance Sheet › Equity › Stockholders' Equity, Number of Shares, Par Value and Other Disclosure › Common Stock, Number of Shares, Par Value and Other Disclosure

us-gaap:CommonStockSharesAuthorized · last filed 2026-08-06

  • 2026-06-30: Common Stock, Shares Authorized 250.00M shares.
  • 2026-03-31: Common Stock, Shares Authorized 125.00M shares.
  • 2025-12-31: Common Stock, Shares Authorized 125.00M shares.
  • 2025-09-30: Common Stock, Shares Authorized 125.00M shares.
Period endCommon Stock, Shares AuthorizedCommon Stock, Shares Authorized as first filed
2026-06-30250.00M shares
10-Q · filed 2026-08-06
2026-03-31125.00M shares
10-Q · filed 2026-05-12
2025-12-31125.00M shares
10-Q · filed 2026-08-06
2025-09-30125.00M shares
10-Q · filed 2025-11-12
2025-06-30125.00M shares
10-Q · filed 2025-08-13
2025-03-31125.00M shares
10-Q · filed 2025-05-15
2024-12-31125.00M shares
10-K · filed 2026-03-12
2024-09-30125.00M shares
10-Q · filed 2024-11-12
2024-06-30125.00M shares
10-Q · filed 2024-08-13
2024-06-12125.00M shares
10-K · filed 2025-03-31
2024-06-1175.00M shares
10-K · filed 2025-03-31
2024-03-3175.00M shares
10-Q · filed 2024-05-10
2023-12-3175.00M shares
10-K · filed 2025-03-31
2023-09-3075.00M shares
10-Q · filed 2023-11-13
2023-06-3075.00M shares
10-Q · filed 2023-08-11
2023-03-3175.00M shares
10-Q · filed 2023-05-15
2022-12-3175.00M shares
10-K · filed 2024-03-08
2022-09-3075.00M shares
10-Q · filed 2022-11-04
2022-06-3075.00M shares
10-Q · filed 2022-08-12
2022-03-3175.00M shares
10-Q · filed 2022-05-13
2021-12-3175.00M shares
10-K · filed 2023-03-30
2021-09-3075.00M shares
10-Q · filed 2021-11-12
2021-06-3075.00M shares
10-Q · filed 2021-08-12
2021-03-3175.00M shares
10-Q · filed 2021-05-07
2020-12-3175.00M shares
10-K · filed 2022-03-24
2020-09-3075.00M shares
10-Q · filed 2020-10-29
2020-06-3075.00M shares
10-Q · filed 2020-08-14
2020-03-3175.00M shares
10-Q · filed 2020-05-07
2019-12-315.00M shares
10-K · filed 2021-03-11
75.00M shares
10-K · filed 2020-02-21
2019-09-3075.00M shares
10-Q · filed 2019-11-06
2019-06-3075.00M shares
10-Q · filed 2019-08-07
2019-04-1275.00M shares
10-K · filed 2020-02-21
2019-03-3175.00M shares
10-Q · filed 2019-05-10
2018-12-3175.00M shares
10-K · filed 2020-02-21
2018-09-3075.00M shares
10-Q · filed 2018-11-02
2018-08-3075.00M shares
10-K · filed 2020-02-21
2018-08-2950.00M shares
10-K · filed 2020-02-21
2018-06-3050.00M shares
10-Q · filed 2018-08-03
2018-03-3150.00M shares
10-Q · filed 2018-05-04
2017-12-3150.00M shares
10-K · filed 2019-03-07
2017-09-3050.00M shares
10-Q · filed 2017-11-03
2017-06-3050.00M shares
10-Q · filed 2017-08-04
2017-05-0550.00M shares
10-K · filed 2018-03-09
2017-03-31500.00M shares
10-Q · filed 2017-05-03
2016-12-3150.00M shares
10-K · filed 2018-03-09
500.00M shares
10-K · filed 2017-02-24
2016-09-30500.00M shares
10-Q · filed 2016-11-04
2016-06-30500.00M shares
10-Q · filed 2016-08-05
2016-03-31500.00M shares
10-Q · filed 2016-05-06
2015-12-31500.00M shares
10-K · filed 2017-02-24
2015-09-30500.00M shares
10-Q · filed 2015-11-02
2015-06-30500.00M shares
10-Q · filed 2015-08-07
2015-03-31500.00M shares
10-Q · filed 2015-05-08
2014-12-31500.00M shares
10-K · filed 2016-03-14
2014-09-30500.00M shares
10-Q · filed 2014-11-12
2014-06-30500.00M shares
10-Q · filed 2014-08-13
2014-03-31500.00M shares
10-Q · filed 2014-05-14
2013-12-31500.00M shares
10-K · filed 2015-03-16
2013-09-30500.00M shares
10-Q · filed 2013-11-13
2013-06-30500.00M shares
10-Q · filed 2013-08-12
2013-03-31500.00M shares
10-Q · filed 2013-05-09
2012-12-31500.00M shares
10-K · filed 2014-03-21
2012-09-30500.00M shares
10-Q · filed 2012-11-08
2012-06-30500.00M shares
10-Q · filed 2012-08-08
2012-03-31500.00M shares
10-Q · filed 2012-05-09
2011-12-31500.00M shares
10-K · filed 2013-03-22
2011-09-30500.00M shares
10-Q · filed 2011-11-09
2011-06-30500.00M shares
10-Q · filed 2011-08-09
2010-12-31500.00M shares
10-K · filed 2012-03-16

Similar stocks

Stock NameCountryMarket CapPE Ratio
RELMADA THERAPEUTICS, INC. (RLMD)United States$0.406B-11.92
Arcturus Therapeutics Holdings Inc. (ARCT)$0.402B-2.05
GALECTIN THERAPEUTICS INC (GALT)United States$0.399B-11.06
ARS Pharmaceuticals, Inc. (SPRY)United States$0.414B-3.70
Atea Pharmaceuticals, Inc. (AVIR)United States$0.414B-2.26
Turn Therapeutics Inc. (TTRX)United States$0.397B-25.68
DiaMedica Therapeutics Inc. (DMAC)United States$0.423B-10.11
PROTHENA CORP PUBLIC LTD CO (PRTA)Ireland$0.428B-11.53
Rezolute, Inc. (RZLT)United States$0.382B-6.45
CYPHERPUNK TECHNOLOGIES INC. (CYPH)United States$0.438B-75.63